+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study



Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study



Journal of Microbiology, Immunology, and Infection 51(5): 621-628



A substantial number of carbapenem-resistant Gram-negative bacilli (CR GNB) have been identified among the etiologic multidrug-resistant GNB in healthcare-associated infections. For achieving a better therapeutic outcome by minimizing inappropriate empirical antibiotic treatment before blood culture and susceptibility testing results are available, it is very important to identify patients who are at risk for the development of CR GNB bacteremia. Retrospective analysis of propensity-score matched (PSM) adult patients with CR GNB bacteremia (PSM-group 1 [n = 95]) and those with non-CR GNB bacteremia (PSM-group 2 [n = 190]). PSM-group 1 was found to a significantly longer length of hospital stay (27 vs. 18 days; p < 0.001) after emerging GNB bacteremia and a higher 30-day all-cause mortality rate (27.4% vs. 5.8%; p < 0.001), when compared with PSM-2 group. Independent risk factors for the acquisition of CR GNB bacteremia were previous exposure to an antipseudomonal penicillin (odds ratio [OR] = 3.58; 95% confidence interval [CI] = 1.30-9.90), an antipseudomonal cephalosporin (OR = 3.49; 95% CI = 1.09-11.24), and a carbapenem (OR = 3.60; 95% CI = 1.37-9.47), and longer length of hospital stay before the development of GNB bacteremia (OR = 1.03; 95% CI = 1.01-1.05). Risk factors for acquisition of CR GNB bacteremia identified in this study each may serve as a reminder alerting clinicians to hospitalized patients at risk for CR GNB bacteremia requiring appropriate antibiotic coverage, and in these circumstances, combined antibiotics may be used until antimicrobial de-escalation/adjustment is clearly indicated by the subsequently identified pathogenic GNB and its susceptibility profile.

(PDF emailed within 0-6 h: $19.90)

Accession: 060210140

Download citation: RISBibTeXText

PMID: 28732563

DOI: 10.1016/j.jmii.2016.08.022


Related references

Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: a matched case-control study. Journal of Microbiology, Immunology, and Infection 44(2): 125-130, 2011

Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study. American Journal of Infection Control 42(6): 621-625, 2015

Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study. Pediatric Infectious Disease Journal 32(2): 140-145, 2013

Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Critical Care Medicine 36(3): 807-811, 2008

Risk factors and outcomes associated with acquisition of colistin-resistant KPC-producing Klebsiella pneumoniae: a matched case-control study. Journal of Clinical Microbiology 48(6): 2271-2274, 2010

Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients. Intensive Care Medicine 39(7): 1253-1261, 2014

The costs of nosocomial resistant gram negative intensive care unit infections among patients with the systemic inflammatory response syndrome- a propensity matched case control study. Antimicrobial Resistance and Infection Control 4(1): 3, 2015

Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. Journal of Antimicrobial ChemoTherapy 60(5): 1124-1130, 2007

Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand. Antimicrobial Agents and ChemoTherapy 62(8), 2018

Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU. Pediatrics 133(2): E322-E329, 2014

Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia. Therapeutic Advances in Infectious Disease 5(1): 11-18, 2018

Risk factors for colistin-resistant Enterobacteriaceae in a low-endemicity setting for carbapenem resistance - a matched case-control study. Euro Surveillance 23(30), 2018

Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study. European Journal of Clinical Microbiology and Infectious Diseases 34(10): 2063-2068, 2016

Antibiotic-resistant Gram-negative bacteremia in pediatric oncology patients--risk factors and outcomes. Pediatric Infectious Disease Journal 32(7): 723-726, 2014

Risk factors for methicillin-resistant Staphylococcus aureus bacteremia: A multicenter matched case-control study. Biomedica 36(4): 612-619, 2018